Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

Market Cap

96.40 Billion CNY

Sector

Healthcare

Website

https://www.tigermed.net

Description

Hangzhou Tigermed Consulting Co.

Read More

Overview

Value

10

Growth

79

Health

77

Management

93

Analyst Opinion

80

Total

68

All Scores Out Of 100

Best Features

  • Very strong cashflow and earnings growth
  • Has a low level of debt
  • Low risk of bankruptcy
  • Has strong financial health
  • Liked by analysts
  • Has strong dividend growth
  • Low preportion of income is paid as dividend

Risk Factors

  • Overvalued on cashflow basis
  • Earnings growth has slowed down recently
  • There is a history of diluting shareholders
  • No margin of safety at their current market price
  • Price-to-earnings ratio of 37.8 is higher than the market average (19.6x)
  • Very safe dividend

Market Peers

300347.SZ

Key Figures

PE Ratio (TTM)

37.76

Margin Of Safety (DCF)

-58.56%

Revenue Growth (5 Year Average)

20.43%

Ratings Consensus

Buy

Share Buybacks

-4.99%

Dividend Yeild (TTM)

0.48%

Valuation

Value Score

10

  • Estimated intrinsic-value of 48.93 CNY is lower than current price ( 114.25 CNY)
  • Price-to-earnings ratio of 37.8 is higher than the market average (19.6x)
  • Free-cashflow-yeild of 1.10% is worse than the market average (4.7%)
  • Margin-of-safety of -58.56% is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: < 42.1 CNY

Current Price: 118.1 CNY

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

37.76x

Free Cashflow Yeild

1.10%

PE/Earnings Growth

0.75

Price/Book

4.49x

Growth

Growth Score

79

  • 5 Year Average Revenue growth of 20.43% is higher than the market average (10.97%)
  • Revenue growth has improved this yeara
  • 5 Year Average Earnings growth of 24.59% is higher than the market average (14.48%)
  • 5 Year Average Cashflow growth of 20.85% is higher than the market average (12.35%)
  • Earnings growth has slowed this year
  • Free Cashflow growth has slowed this year

Revenue Growth

20.43%

Earnings Growth

24.59%

Cashflow Growth

20.85%

Health

Health Score

77

  • Low risk of bankruptcy
  • Has a low level of debt
  • Assets cover liabilities
  • Low financial Leverage
  • Normal operation does not require debt to be sustainable
  • Debt repayments do not significantly impact cashflow

Altman Z Score

13.45

Piostroski Score

4.00

Debt/Equity

0.07x

Current Assets/Liabilities

4.50x

Free Cashflow/Total Debt

0.89x

Debt/Capital

0.11x

Dividend

Secure Dividend Score

80

  • Very safe
  • Long term dividend payout ratio of 20.95% is considered good
  • Payout ratio (TTM) of 17.68% is lower than the average (40%)
  • Dividends have shown growth over the last 5 years
  • Spending a lower percentage of their income on dividends than last 5 years
  • Dividend yeild of 0.48% is less than the market average (1.85%)
  • Dividend growth has been slowing recently

Dividend Yeild

0.48%

Dividend Growth

4.77%

Payout Ratio (Earnings)

17.68%

Payout Ratio (Cashflow)

43.44%

Management

Management Score

93

  • Has issued new shares to finance growth when share price is high
  • Has returned higher dividends when earnings have risen
  • Return-on-equity of 15.41% is higher than the market average (15%)
  • Return-on-capital-employed of 13.65% is higher than the market average (10%)
  • Has a history of diluting shareholders to finance activity

Average Buybacks/Dilution

-4.99%

Recent Buybacks/Dilution

-2.83%

5 Year Price Volitility

60.21%

Return On Assets

11.76%

Return On Capital Employed

13.65%

Return On Equity

15.41%

Return On Free Cashflow

331.62%

Return On Investments

29.40%

Analysts

Analyst Opinion

80

  • Ratings consensus is Buy

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Hangzhou Tigermed Consulting Co., Ltd.

Currency

CNY

Beta

0.811374

Vol Avg

6647884

Ceo

Cik

Cusip

Exchange

Shenzhen

Full Time Employees

8326

Industry

Diagnostics & Research

Sector

Healthcare

Ipo Date

2012-08-17

Address

F18, Building A – Shengda Science Park

City

Hangzhou

State

Country

CN

Zip

310051

Phone

86 57 1288 87227

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies